November 30, 2018

November 30, 2018

New cancer treatment credited for saving the life of 9-year-old boy

Good Morning America – Nov. 27

"When you find a patient that has the mutation that this drug targets, it works almost every time," said Dr. Damon Reed, a pediatric oncologist at Moffitt Cancer Center.


Women with dense breasts or family history of breast cancer should start regular scans from age of 30 not 50

Daily Mail – Nov. 28

'The reason that it's getting attention is because there are a lot more people who do have it than those who have genetic mutations,' Dr. R Jared Weinfurtner, MD, a radiologist at Moffitt Cancer Center, told 


Many US Cancer Centers Accused of Misleading Advertising

Medscape – Nov. 29

The cancer centers include such prestigious institutions as MD Anderson in Houston, Memorial Sloan Kettering in New York City, Dana-Farber in Boston, and Moffitt in Tampa, Florida.


Organizations push to raise awareness at World Aids Day event

Tampa Bay Times – Nov. 29

A World AIDS Day awareness event in Tampa Saturday (Dec. 1) will feature health experts, onsite HIV screening and health and wellness vendors including Metro Wellness, Moffitt Cancer Center and Florida Family Health Center.


Hospitals square off over bone marrow transplants

Panama City News Herald – Nov. 28

There were 1,079 bone marrow transplants conducted in Florida from July 2017 to June 2018, according to a September report. Those procedures were conducted at six hospitals: University of Miami Hospital and Clinics, Memorial Hospital West, Florida Hospital, H. Lee Moffitt Cancer Center & Research Institute Hospital, Mayo Clinic and UF Health Shands Hospital.


Vita Vea Giving the Tampa Bay Buccaneers Foundation Home Field Advantage During My Cause, My Cleats Campaign – Nov. 28

“We went to Metropolitan Ministries with the Rookie Club and Moffitt Cancer Center,” Vea said of the events that inspired him to get more involved with the Foundation. “We did trick-or-treating with the patients and stuff like that. Going into the community and trying to bring a smile to people’s faces and spread positivity.”


Dr. Komrokji Discusses the FDA Approval of Gilteritinib for FLT3+ AML

OncLive – Nov. 28

Rami S. Komrokji, MD, principal investigator, MDS Research Consortium, Aplastic Anemia and MDS International Foundation, clinical director, Hematologic Malignancies, Moffitt Cancer Center, discusses the FDA approval of gilteritinib (Xospata) for the treatment of adult patients with FLT3mutation–positive relapsed or refractory acute myeloid leukemia (AML).


This man's 'beer belly' turned out to be a 77-pound tumor

Yahoo – Nov. 28

“There’s no way in terms of symptoms to definitively say ‘This is due to cancer and this is not,’” John Mullinax, MD, a surgical oncologist in the Sarcoma Department at Moffitt Cancer Center, tells Yahoo Lifestyle. “Any unexplained change in weight should be checked out.”


WINSTON | BAKER Co-Founder Amy Baker Joins Moffitt's National Board of Advisors – Nov. 28

Moffitt Cancer Center is pleased to announce the appointment of Amy Baker, co-founder and managing partner of WINSTON | BAKER, to its national Board of Advisors. 


Trove of brain cancer data available for study through Georgetown platform

Healio – Nov. 27

Question: How did this data set come about?

Answer: This project was developed by the NCI. Specifically, it was a project of the Glioma Molecular Diagnostics Initiative. There were 14 contributing institutions, including The University of Texas MD Anderson Cancer Center, Moffitt Cancer Center, Duke University, Henry Ford Cancer Institute, Dana-Farber Cancer Institute and the NCI. The database contains clinical information and genomic data for patients with brain tumors as part of this research study. 


Midlife PSA levels predict risk for aggressive prostate cancer among black men

Healio – Nov. 27

“While these findings do not imply that these younger men should immediately undergo prostate biopsy or definitive treatment, they suggest that this group would benefit from more intensive PSA screening for earlier identification of cancer while it is potentially curable,” Travis Gerke, ScD, epidemiologist at Moffitt Cancer Center, said in a press release. 


FDA Approves Drug That Targets Key Genetic Driver of Cancer

Technology Networks – Nov. 27

“For patients with this specific mutation, Vitrakvi is a magic bullet that works almost every time,” said Dr. Damon Reed, associate member of Moffitt’s Sarcoma Program and leader of its Adolescent and Young Adult Program.


Delayed Prostate Cancer Treatment May Up Relapse Risk

Renal and Urology News – Nov. 26

“Time to receive treatment or treatment delays is an important quality metric in patient-centered care that has been shown to impact outcome among various cancers,” said study investigator Kosj Yamoah, MD, PhD, an oncologist and an Assistant Professor in the Department of Radiation Oncology and Cancer Epidemiology at H. Lee Moffitt Cancer Center in Tampa, Florida. 


New Chemotherapy Combination Offers Improved Outcomes in Bladder Cancer

Cure – Nov. 26

So, a team from the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida, evaluated rates and the association of any downstaging, complete response and overall survival with neoadjuvant ddMVAC compared with gemcitabine and cisplatin.


Large study of black men with prostate cancer to look beyond genetics

Healio – Nov. 26

The collaborative effort — funded by grants from NCI, the National Institute on Minority Health and Health Disparities, and the Prostate Cancer Foundation — will include investigators from several other institutions and entities: Rutgers Cancer Institute of New Jersey, New Jersey State Cancer Registry, New Jersey Department of Health, Public Health Institute, Emory University, Johns Hopkins University, LSU Health New Orleans, Baylor College of Medicine, Moffitt Cancer Center, Barbara Ann Karmanos Cancer Institute/Wayne State University and University of California, San Francisco.


Marco Island woman needs help with medical bills

WFTX – Nov. 23

Laura travels to Moffitt Cancer Center in Tampa once a week for treatment, soon she will need a mastectomy.


Why Is the 5-Year Survival Rate for Ovarian Cancer So Low?

Nov. 21 – Self Magazine

Unfortunately, these are vague symptoms that can also be caused by so many other, more common conditions, Mitchel Hoffman, M.D., a gynecologic oncologist at Moffitt Cancer Center, tells SELF. (Or even just life habits, like often eating things that make you feel bloated.)


Tampa Bay family raises $1 million for brain cancer research in mom's honor

WTSP – Nov. 20

In the last decade, they’ve raised about $1 million towards cancer research. The money goes to families at Moffitt Cancer Center and Johns Hopkins Hospital.=


What I'm Thankful For on this Thanksgiving | Carmen Catches Up – Nov. 22

Whether it’s the offensive line donating $35,000 to give over 1,000 Bay-area families Thanksgiving meals, select players pitching in to help a Tampa woman, who they met through a Social Justice Initiative visit, get a car, or reverse trick-or-treating with cancer patients at Moffitt Cancer Center for Halloween, I’m so grateful for these players that want to make an impact on their community. 


Managing uncertainty in Spitz Nevi melanoma

eCancer – Nov. 22

Prof Vernon Sondak - H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, speaks with ecancer at the EADO 2018 congress in Barcelona about managing the uncertainty of Spitz Nevi melanoma.



Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.